BAL PHARMA LIMITED

Analyst Reco. Bal Pharma Limited

Equities

BALPHARMA

INE083D01012

Market Closed - Bombay S.E. Other stock markets 06:00:48 2024-05-16 am EDT			5-day change	1st Jan Change
100.4 ^INR	+1.34%		+1.87%	-0.07%

Feb. 12	Bal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	Bal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Acuite Keeps BBB- Rating on Bal Pharma's Bank Loans; Outlook Stable	23-04-25	MT
Acuite Upgrades Rating on Bal Pharma's Fund-Based Financing to BBB-; Lowers Outlook to Stable	22-02-22	MT
ICRA Maintains BB+ Rating on Bal Pharma's Long-Term Bank Financing; Raises Outlook to Positive	21-12-21	MT
Bal Pharma : ICRA Raises Rating on Bal Pharma's Fund-Based Financing, Term Loan to BB+; Keeps Stable Outlook	21-09-14	MT
Bal Pharma : ICRA Reaffirms Bal Pharma's Fund-Based Facilities BB Rating; Raises Outlook to Stable	21-03-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW